Iva Dincheva is an intellectual property lawyer who represents clients across a range of industries in the life-sciences. She has deep understanding of a variety of molecular technologies such as DNA and RNA diagnostics, antibody- and small molecule-based therapeutics, and other biologics. Dr. Dincheva has extensive practical experience in patent prosecution and in-depth analysis of patent infringement, invalidity and freedom to operate. Dr. Dincheva is a registered patent agent with the USPTO.

Dr. Dincheva joined WilmerHale as a technology specialist in 2018, focusing on prosecuting domestic and international patent applications in the pharmaceutical industry and the broader field of life sciences. While earning her JD degree from the Fordham University School of Law, she was a technology specialist at WilmerHale, helping clients transfer their scientific discoveries into patent applications.

Prior to joining WilmerHale, Dr. Dincheva was a postdoctoral research scientist at Columbia University, evaluating the role of serotonergic neurons in regulating emotional behaviors.

Dr. Dincheva received her doctorate from Weill Cornell Medical College in the field of biomedical sciences/pharmacology. During her doctorate training at Weill Cornell Medical College Dr. Dincheva discovered a “sensitive period” in mouse development with long-term effects on anxiety behaviors and established a treatment protocol, which prevents anxiety behaviors in mutant mice.

Selected Publications

• Dincheva I, et al. Early-life FLX rescues anxiety-like behaviors in BDNFVal66Met mice. AJP. 2017
• Dincheva I, et al. The Role of BDNF in the Development of Fear Learning. Depress. Anxiety. 2016
• Dincheva I, et al. FAAH genetic variation enhances fronto-amygdala function. Nat Commun. 2015
• Dincheva I, et al. BDNF modulates contextual fear learning during adolescence. Dev Neurosci. 2014